[Evaluation of lipoprotein (a) and fibrinogen levels in men after premature myocardial infarction and in their sons].
Lipoprotein (a) and fibrinogen admittedly are independent risk factors of coronary heart disease. Since Lp (a) has been shown to inhibit plasminogen binding to endothelial cells and to fibrin monomers, this led to the speculation that high Lp (a) levels in plasma could interfere with fibrinolysis. Therefore the aim of our work was to estimate the lipoprotein (a) and fibrinogen levels and to find correlation between lipoprotein (a) and fibrinogen levels at the men after a myocardial infarction and also at their sons. We examined 33 men of age 31-57 after a myocardial infarction and their 18 sons 4-14 years old. The control group consisted of 40 men of age 18-57 and their 19 sons 5-14 years old. The Lp (a) was determined with electroimmunodiffusion method and fibrinogen by Clauss method. The fibrinogen level in the examined group was found to be statistically significantly higher (338 mg/dl) than in the control group (313 mg/dl). There was no correlation between Lp(a) and fibrinogen concentration. In the group of sons of patients mean fibrinogen and Lp (a) levels were similar to those of the control group. However there was a negative correlation between the fibrinogen and the triglycerides concentration in sons of patients but not in the control group. The results seem to confirm the significance of fibrinogen as a risk factor for the development of the coronary heart disease.
Bobins
M
M
Regionalne Centrum Badań Nad Miazdzyca, Pomorska Akademia Medyczna w Szczecinie.
Klinke
M
M
Jastrzebska
M
M
Chełstowski
K
K
Bukowska
H
H
Naruszewicz
M
M
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005340:Fibrinogen / Q000032:analysis*; D006801:Humans; D017270:Lipoprotein(a) / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood*; D012307:Risk Factors
D017270:Lipoprotein(a); D005340:Fibrinogen
Ocena stezenia lipoproteiny (a) i fibrynogenu u mezczyzn po wcześnie przebytym zawale mieśnia sercowego oraz u ich synów.